Artificial intelligence (AI) can now simulate human reasoning, learn from new information and make predictions. The value of AI was recently demonstrated in the COVID-19 pandemic, whereby AI-based approaches were used to accelerate mRNA vaccine antigen design and the conduct clinical trials, helping developers to go from a viral sequence to approved product in less than one year. But we are still in early days. In addition to machine and deep-learning, generative AI will transform vaccine development faster than we ever imagined. /immunization-vaccines-and-biologicals-(ivb)/product-delivery-research-(pdr)/gvirf-ai-vx-rd_flyer_final.tmb-xs.jpg?sfvrsn=e6f60b90_1)
In this webinar we will explore
- What is AI?
- The history and applications of AI
- How to collect and format data for global use
- AI approaches in Vaccine Discovery
- Antigen and epitope discovery
- Rational vaccine design
- AI approaches in Vaccine Development
- Product optimization / manufacturing
- Clinical design and execution
- Regulatory considerations
Expert panel discussions will focus on lessons learned, challenges, risks and opportunities using AI to accelerate vaccine development against global threats.